Basic Information
Basic information for SNHG14-285-44aa
Peptide Name SNHG14-285-44aa
Genome Position chr15:25249014-25249145[+]
Species Human
Peptide Sequence MVSLEEDLYWDPTGPRPVSVSLVLIPQCAEAQTLPGTLVSCTEL
Peptide Length 44
Unique No (SNHG14-225-44aa,SNHG14-228-44aa-2,SNHG14-229-44aa,SNHG14-243-44aa,SNHG14-244-44aa,SNHG14-245-44aa,SNHG14-266-44aa,SNHG14-267-44aa,SNHG14-273-44aa,SNHG14-284-44aa,SNHG14-292-44aa-1,SNHG14-294-44aa,SNHG14-295-44aa,SNHG14-306-44aa,SNHG14-317-44aa,SNHG14-326-44aa,SNHG14-327-44aa,SNHG14-328-44aa,SNHG14-329-44aa,SNHG14-331-44aa)
Grand Average of Hydropathicity 0.2977
Relative Molecular Mass 5534.24
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000224078;SNHG14
Transcript ID/Name ENST00000663446;SNHG14-285
Transcript Length 5976
Coding Ability 0.5197
DNA Sequence Corresponding to Peptide ATGGTGAGCCTGGAGGAAGACTTGTATTGGGACCCTACAGGCCCCAGGCCAGTGTCTGTCAGCCTGGTGCTCATCCCCCAGTGCGCTGAAGCTCAGACCCTCCCTGGCACCCTGGTCTCCTGCACTGAGCTG
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :